+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adult Hemoglobinopathy Testing Market by Modality (Laboratory Based Tests, Point Of Care Tests), Disease Type (Hemoglobin C Disease, Sickle Cell Disease, Thalassemia), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Adult Hemoglobinopathy Testing Market by Modality (Laboratory Based Tests, Point Of Care Tests), Disease Type (Hemoglobin C Disease, Sickle Cell Disease, Thalassemia), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Adult Hemoglobinopathy Testing Market by Modality (Laboratory Based Tests, Point Of Care Tests), Disease Type (Hemoglobin C Disease, Sickle Cell Disease, Thalassemia), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887529
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Adult hemoglobinopathy testing is experiencing significant momentum as both clinical necessity and technological advancements drive deeper integration of advanced diagnostic solutions across global healthcare systems. As the urgency for timely, accurate detection of hereditary blood disorders grows, industry leaders face a dynamic landscape shaped by regulatory evolution, supply chain considerations, and distinct regional drivers.

Adult Hemoglobinopathy Testing Market Snapshot

The Adult Hemoglobinopathy Testing Market grew from USD 5.10 billion in 2024 to USD 5.41 billion in 2025. It is expected to continue growing at a CAGR of 5.86%, reaching USD 7.18 billion by 2030. Persistent demand is being fueled by evolving diagnostic technologies, global migration patterns, and the growing importance of early identification, carrier screening, and ongoing disease management. As healthcare infrastructures strengthen, both centralized laboratory testing and rapid point-of-care modalities play pivotal roles in patient care.

Scope & Segmentation of the Global Market

  • Testing Modalities: Laboratory-based tests such as electrophoresis, genetic analysis, and high performance liquid chromatography; point of care and rapid testing options.
  • Disease Coverage: Hemoglobin C disease, sickle cell disease, and thalassemia variants including alpha, beta, and delta subtypes.
  • End User Segments: Diagnostic laboratories (hospital, independent, reference), secondary and tertiary care hospitals, and research institutes.
  • Distribution Channels: Direct sales, local and regional distributors, online vendors.
  • Geographic Reach: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (with leading and emerging centers), and Asia-Pacific (including China, India, Japan, Australia, and others).
  • Key Market Participants: Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott Laboratories, Bio-Rad Laboratories, Ortho Clinical Diagnostics Inc., Danaher Corporation, Becton, Dickinson and Company, PerkinElmer Inc., Sysmex Corporation.

Primary Keyword: Adult Hemoglobinopathy Testing

Key Takeaways for Senior Decision-Makers

  • Advanced genotyping and automated laboratory methods are redefining diagnostic pathways, leading to improved accuracy in hemoglobin variant profiling and faster patient results.
  • Strategic collaborations—between technology providers, reagent manufacturers, and healthcare organizations—are mitigating supply chain risks and optimizing product delivery despite regulatory shifts.
  • Cloud-based data systems are facilitating continuous patient monitoring and data-driven therapeutic adjustments, aligning diagnostics with evolving precision medicine frameworks.
  • Point-of-care testing adoption is rising rapidly in outpatient and emergency settings, supplementing centralized laboratory capabilities and expanding access in resource-limited regions.
  • Integration of multiplexed assays is enabling simultaneous screening for multiple hemoglobin disorders, streamlining workflow for end users in diagnostic and hospital laboratories.
  • Regional funding mechanisms, infrastructure development, and policy harmonization are accelerating the deployment of both laboratory and rapid-testing models worldwide.

Tariff Impact on Supply Chains

The implementation of cumulative tariffs on diagnostic reagents and instrumentation in 2025 prompted clinical laboratories and suppliers to re-evaluate sourcing and manufacturing strategies. Local partnerships are being pursued to reduce import dependency. Supply cycles have lengthened, necessitating inventory adjustments and volume-based procurement to maintain competitive pricing. Diagnostic companies are investing in regional production and technology transfer agreements, increasing flexibility and long-term resilience across the value chain.

Methodology & Data Sources

This report utilizes interviews with hematologists, laboratory directors, and industry executives, alongside comprehensive secondary research from journals, regulatory filings, and industry reports. Analytical approaches include SWOT assessment and value chain mapping, with validation through cross-referenced expert insights and official trade data.

Why This Report Matters

  • Senior decision-makers gain actionable insights for strategic investments in diagnostic technologies and market entry or expansion opportunities.
  • Clear analysis of evolving regulatory, supply chain, and reimbursement environments supports informed resource allocation and operational planning.
  • Comprehensive market segmentation equips executives with targeted intelligence to optimize product portfolios and respond promptly to changing clinical and regional demands.

Conclusion

Adult hemoglobinopathy testing stands at the crossroads of technology, policy, and patient need. With data-driven, actionable intelligence, leadership teams can position their organizations to enhance diagnostic access, foster innovation, and achieve competitive differentiation in this evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in next-generation sequencing assays for adult hemoglobinopathy diagnostics
5.2. Integration of AI-driven digital microscopy solutions for accurate adult hemoglobinopathy diagnosis
5.3. Expansion of point-of-care hemoglobinopathy testing using microfluidic paper-based analytical devices
5.4. Growing adoption of high-throughput mass spectrometry for comprehensive adult hemoglobin variant profiling
5.5. Emergence of noninvasive prenatal screening platforms impacting adult hemoglobinopathy risk assessment
5.6. Development of multiplex PCR assays targeting rare hemoglobinopathy mutations in adult populations
5.7. Increase in telemedicine-enabled genetic counseling services for adult hemoglobinopathy management
5.8. Impact of regulatory approvals on commercialization of novel adult hemoglobinopathy diagnostic kits
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Adult Hemoglobinopathy Testing Market, by Modality
8.1. Introduction
8.2. Laboratory Based Tests
8.2.1. Electrophoresis
8.2.2. Genetic Analysis
8.2.3. High Performance Liquid Chromatography
8.3. Point Of Care Tests
8.3.1. Rapid Tests
9. Adult Hemoglobinopathy Testing Market, by Disease Type
9.1. Introduction
9.2. Hemoglobin C Disease
9.3. Sickle Cell Disease
9.4. Thalassemia
9.4.1. Alpha Thalassemia
9.4.2. Beta Thalassemia
9.4.3. Delta Thalassemia
10. Adult Hemoglobinopathy Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Laboratories
10.2.2. Independent Laboratories
10.2.3. Reference Laboratories
10.3. Hospitals
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Research Institutes
11. Adult Hemoglobinopathy Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. Local Distributors
11.3.2. Regional Distributors
11.4. Online Vendors
12. Americas Adult Hemoglobinopathy Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Adult Hemoglobinopathy Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Adult Hemoglobinopathy Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Diagnostics International AG
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Siemens Healthineers AG
15.3.4. Abbott Laboratories
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Ortho Clinical Diagnostics Inc.
15.3.7. Danaher Corporation
15.3.8. Becton, Dickinson and Company
15.3.9. PerkinElmer, Inc.
15.3.10. Sysmex Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ADULT HEMOGLOBINOPATHY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ADULT HEMOGLOBINOPATHY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ADULT HEMOGLOBINOPATHY TESTING MARKET: RESEARCHAI
FIGURE 24. ADULT HEMOGLOBINOPATHY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. ADULT HEMOGLOBINOPATHY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. ADULT HEMOGLOBINOPATHY TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RAPID TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 124. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 125. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 126. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 127. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 128. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 129. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 132. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 133. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 136. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 137. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 142. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 259. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 268. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 269. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 278. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 279. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Adult Hemoglobinopathy Testing market report include:
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Sysmex Corporation

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.18 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Adult Hemoglobinopathy Testing - Global Strategic Business Report - Product Image

Adult Hemoglobinopathy Testing - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Hemoglobin Testing Market by Test Type (Lab Based, Point Of Care), Technology (High Performance Liquid Chromatography, Spectrophotometry), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030 - Product Image

Hemoglobin Testing Market by Test Type (Lab Based, Point Of Care), Technology (High Performance Liquid Chromatography, Spectrophotometry), End User, Distribution Channel, Sample Type - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report - Product Image

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

  • Report
  • 511 Pages
  • Global
From
Glycated Hemoglobin Testing Market by Test Type (HbA1c Laboratory Testing, Point-of-Care HbA1c Testing), Product Type (Instruments, Kits & Reagents), Technology Platform, Indication, End Users, Distribution Channel - Global Forecast 2025-2030 - Product Image

Glycated Hemoglobin Testing Market by Test Type (HbA1c Laboratory Testing, Point-of-Care HbA1c Testing), Product Type (Instruments, Kits & Reagents), Technology Platform, Indication, End Users, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Hemoglobin Testing Market Report by Product Type, Technology, End-User, and Region 2024-2032 - Product Image

Hemoglobin Testing Market Report by Product Type, Technology, End-User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.